Thursday, May 03, 2018 11:57:22 AM
At the beginning of March I decided to catch a plane and head for the meeting on March 7 to get some answers and take a closer look at the facility. I arrived to Las Vegas with one thought in my mind; that if I didn't like what I found out about the financial report (last) or if I had any doubt about the business goals or the operation, I would close my position. It turned out to be a very enlightening trip. So much so, that I increased my position by 74%.
If you have a doubt about any aspect of the operation, business model, financials or how the money is being spent, go to the source and find out. Do us all a favor and write management or give them a call until someone clears your doubts. They are not BOTs, they are human beens.. If you can't get any acceptable feedback and the anguish is unbearable CLOSE the position.
In short: channel your negative feelings in a proactive manner and get something out of it. You could be right and spare yourself the suffering and save some money.. I try not to stay where I don't feel confortable. There are plenty of other plays in this space.
When I met the CEO, John Poss gave me the answers that filled in the blanks in my mind. He answered all my questions and treated me very well . He is a true gentleman. He thinks of one thing only: How to increase the value proposition of the company in an affordable manner. And the final objective will always be the same, no matter which road we take; to produce top quality and replicable cannabis medicine.
Recent GBLX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM